Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
about
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaHigh resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.Relationship between EGFR expression, copy number and mutation in lung adenocarcinomasA pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patientsAdvanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors.Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.How close are we to customizing chemotherapy in early non-small cell lung cancer?Epidermal growth factor receptor gene mutations in patients with lung adenocarcinoma differ by frequency and type between Uighur and Han ethnic groups in Xinjiang Autonomous Region.Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose RadiotherapyGenetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma.Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR MutationsClinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure.Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma.KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies.Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action.How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single InstitutionEGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical features.Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status.Frequency and Spectrum of KRAS Mutations in Moroccan Patients with Lung Adenocarcinoma.Molecular targets in the treatment of non-small-cell lung cancer: is there hope on the horizon?The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.KIT as a therapeutic target in melanoma.KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapy.Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer.EGFR and KRAS mutation analyses from specimens obtained by bronchoscopy and EBUS-TBNA.The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.Utilization of cell-transferred cytologic smears in detection of EGFR and KRAS mutation on adenocarcinoma of lung.
P2860
Q28303718-193CFFC9-1BDE-4ABA-A2BA-4B22ECFB0E6CQ33336861-F74DB963-D0C7-4B5A-BD6E-5783BE16E149Q33634703-286ACB9A-0175-4D24-A5D5-04C9F23780E6Q33702017-4EAFAB1A-5C4A-49E2-A60A-2EF782C01FD0Q34303294-D46B4AE1-2FE2-410B-A5FF-E18CB68E48E0Q34385995-C4C7C2F4-D20D-422D-8511-FB2CCCD79E6DQ35146944-57C04F81-7B27-4333-BF08-F258FADB5073Q35164907-678FBA5D-E971-49D7-AA3D-8454942EBA50Q35623628-A1D6FCB8-ABBF-46E6-BE65-8E3061C6705BQ35897344-B7A86117-A73A-4E6E-A9A2-8FF78C1D3AA3Q36187075-6C2C895F-6EE7-48D9-B682-C73DB7BDCC99Q36272122-C119E8ED-DE81-479A-98AC-09C42BAB0249Q36844350-E19DB58A-9BF2-4174-873D-92FA5EBDA38CQ36946809-3FBDC1F0-39B0-4469-A79A-1A75894BA952Q37039303-9ED08B93-FDA7-46EA-814D-5E26F43674B8Q37245907-C9727153-86E1-4B2A-B30B-8C0A91C50B39Q37421036-5FF00971-BC89-4B4F-9B63-865EFB9BA985Q37567804-9BDD6092-BD9D-4212-BB1C-AB05F976D812Q37651033-4471B3DF-F38C-4CB9-A77D-06F19F09AADDQ38267142-C3664199-A00F-4E06-8059-C6EA3FF5AF07Q38306683-B5C585FD-592E-45B4-A452-AD8B3CFEEE97Q39364958-CC80E656-BD64-4BDB-853C-940400E583C1Q40542208-3AC30D74-51B3-4F78-A97A-96ADBE322EE3Q40838225-9EA6088E-80A2-467A-8705-36EBFD4CE1B7Q44070495-670DE56D-E625-494B-AAB3-740E25543983Q44658636-26367723-54FD-488B-9B56-DBB931A13F37Q47864863-880BBC19-87EF-4013-B02F-E1317A31E22BQ47896382-4CF7C903-7A6A-4429-8F93-E19F841DC4AAQ54339322-92046BFD-4CAE-4BDB-BFCD-5C87EF012259Q54390545-6E80FB6E-6791-48EE-B60F-E3F263FABD83
P2860
Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Molecular changes of epidermal ...... ed adenocarcinoma of the lung.
@en
type
label
Molecular changes of epidermal ...... ed adenocarcinoma of the lung.
@en
prefLabel
Molecular changes of epidermal ...... ed adenocarcinoma of the lung.
@en
P2093
P1433
P1476
Molecular changes of epidermal ...... ed adenocarcinoma of the lung.
@en
P2093
Chang Hyun Kang
Dong Soon Lee
Hee Jung Kang
Hyo-Seon Choi
Joo Hyun Kim
Ju-Yeon Park
Seokyung Hahn
Sook Whan Sung
Soon-Jung Seo
Sun Jung Park
P304
P356
10.1016/J.LUNGCAN.2007.08.008
P577
2007-09-29T00:00:00Z